An oncolytic measles virus (MV) platform was modified with the aid of the H. pylori-derived NAP to activate macrophages in GBM via TLR2 targeting and promoting the secretion of the high-mobility group box1 protein (HMGB1). This evidence concerns the gene TLR2 and glioblastoma.